"&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nThe way we behave as PHE members of staff will have the greatest impact in achieving our ambitions as\n an organisation. What we say matters but what we do matters more.\n  \nOur effectiveness depends on how we behave so we will:\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nPHE is committed to supporting all its employees but recognises that there are specific actions that can help to support women in a scientific role within the organisation.   \n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nIt is the polic\ny of Public Health England (PHE) to work in co-operation with the pharmaceutical, biotechnology, vaccine, diagnostic, and other healthcare-related industries in order to facilitate the development of products and technologies beneficial to health. Health p\nrotection consultancy services are also provided to a wide range of companies. These relationships are managed on an arms-length, contractual and commercial basis, including the charging of fees under standard terms and conditions. In this context, PHE mai\nntains active relationships with a broad range of companies in the UK and internationally. PHE has a comprehensive system for managing conflicts of interest.\n&#xa0;\nAugust 2013\n&#xa0;\n Health Protection Agency Annual Report and Accounts 2011-12, p 38\n Public Health England\n,\n Conflict of Interest Policy and Procedure.\n"